As one of the leading global suppliers of ion exchange resins into the pharmaceutical formulation area, Rohm and Haas continues to invest in improving ways to manufacture the drug resinates and expand the uses of functional polymers.

 

Based on an on-going, dedicated work programme, Rohm and Haas has recently filed patents in the following areas:

 

• Extended Release formulations

 

• Modified Release formulations

 

• Improved Dissolution test methods

 

• Reduced Abuse technologies

 

• Deliquescent Drugs

 

• Polymorphism

 

• Poorly Soluble Drugs

 

 

Our ART Formulation Lab can hep you to:

 

• Get to market more quickly and improve the effectiveness of your formulation,

 

• Save time - We can perform you initial resinate screening,

 

• Simplify your life - We can produce resinates for your lab trials (up to 5 kg scale / non-cGMP).

 

 

For further details, please contact Mr. Marlin K. Kinzey

 

 

Back